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Abstract 
There is a need to develop pro-angiogenic biomaterials to promote wound healing and to assist in 
regenerative medicine. To this end, various growth factors have been exploited which have the 
potential to promote angiogenesis. However these are generally expensive and labile which 
limits their effectiveness. An alternative approach is to immobilize heparin onto biocompatible 
degradable hydrogels. The heparin in turn will then bind endogenous proangiogenic growth 
factors to induce formation of new blood vessels. 
In this study we continue our development of hydrogels for wound healing purposes by 
exploring covalently cross-linking chitosan (CS) and polyvinyl alcohol (PVA) hydrogels using 
triethyl orthoformate (TEOF) .Two concentrations of TEOF ( 4 and  16 %) were compared for 
their effects on the structure of hydrogels -their swelling, pore size  and rate of degradation and 
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for their ability to support the growth of cells and for their heparin binding capacity and their 
effects on  angiogenesis in a chick chorioantoic membrane assay .  
Hydrogels formed with 4 or 16% both TEOF cross-linker were equally cyto-compatible. 
Hydrogels formed with 4% TEOF absorbed slightly more water than those made with 16% 
TEOF and broke down slightly faster than non-cross-linked hydrogels. When soaked in heparin 
the hydrogel formed with 16% TEOF showed more blood vessel formation in the CAM assay 
than that formed with 4% TEOF. 
Introduction 
Many wounds do not heal properly and skin grafts and tissue engineered skin grafts do not 
³WDNH´ RQ ZRXQG EHGV EHFDXVH RI SRRUO\ YDVFXODUL]HG ZRXQG EHGV 7KLV SUREOHP LV well 
known as discussed in MacNeil 20071. Angiogenesis is the sprouting of new capillaries from 
preexisting vasculature and it requires a complex multistep process involving the adhesion, 
proliferation, and differentiation of endothelial cells and helper cells2.  
Over the years there have been many attempts to induce angiogenesis by adding pro-
angiogenic growth factors to wounds or to introduce glycosaminoglycans such as heparin 
which in turn will bind angiogenic growth factors (AGFs). To induce angiogenesis, AGFs 
must interact with pro-angiogenic receptors to induce proliferation, protease production and 
migration of endothelial cells (ECs)3, 4. Research over the last decade has shown that vascular 
endothelial growth factor (VEGF) has a fundamental role as a regulator of normal and 
abnormal angiogenesis. VEGF is essential for early development of the vasculature to the 
extent that inactivation of even a single allele of the VEGF gene results in embryonic 
lethality5, 6. Similarly, the Fibroblast growth factor (FGFs) family has been identified in a 
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variety of organisms to play a significant role in many cellular processes including 
angiogenesis, mitogenesis, differentiation, migration, and cell survival 7.  
Heparin undoubtedly plays a pivotal role in this context since it binds to almost all the known 
AGFs, to several pro-angiogenic receptors and even to angiogenic inhibitors, producing an 
intricate network of interactionsWKHVRFDOOHG³DQJiogenesis glycomiFLQWHUDFWRPH´8, 9. 
Many researchers have used heparin to promote angiogenesis by loading it onto different 
polymeric materials 10-13. In particular they have used heparin loaded with VEGF to bind and 
stabilize VEGF which has a short half -life when added to wound beds on its own14-16.  
The current study continues our work in producing a hydrogel which can electrostatically bind 
heparin and stimulate angiogenesis while having a number of other desirable properties for 
clinical use. We are seeking to produce biocompatible biodegradable hydrogels which can be 
added to poorly vascularized wound beds which will stimulate the development of a 
temporary neo-dermis with new blood vessel formation.  Previously, we successfully cross-
linked CS and PVA using a fixed concentration of triethyl orthoformate (TEOF)17. In this 
study we have deliberately altered the concentration of TEOF to try to determine to what 
extent this influences material morphology, swelling behavior, the rate of degradation of the 
biomaterials produced, the binding of heparin and their subsequent effect on angiogenesis.   
Chemical cross-linking is a very useful process to fabricate materials which combine the best 
properties of two different materials with different desirable properties. A combination of 
biocompatible polymers with synthetic polymers can enhance their mechanical, physical, 
biological and chemical properties, making them suitable for complex biological systems. 
Such composites reduce the disadvantages of each individual polymer whilst maximizing the 
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optimum properties of each in the resulting combined entity 18, 19. One method of obtaining 
the required properties from natural and synthetic polymers is to blend and crosslink them 20.  
Hydrogels have the capability to swell in water, trapping larger amounts within their structure 
without dissolving. They have physical properties similar to some aspects of the extracellular 
matrix and have excellent tissue compatibility. The only disadvantage of hydrogels is their 
poor mechanical properties after swelling. To overcome this disadvantage, hydrogels haves 
EHHQ PRGL¿HG E\ SK\VLFDO EOHQGLQJ 21-24 or chemical crosslinking methods methods25-27. In 
particular chitosan in combination with other polymers has opened a new window of research 
for altering or tailoring the properties of materials 28-30. Hydrogels of PVA and CS are non-
toxic and biodegradable and hydrogels composed of such combinations are expected to have 
high biocompatibility 31. 
In this study we demonstrate that the characteristics of these PVA/CS hydrogels are tunable 
by altering the degree of cross-linker used. We describe a TEOF cross-linked hydrogel with 
properties suitable for converting a poorly vascularized wound bed into a neo-dermis with 
new vasculature which we suggest is now suitable for evaluation in vivo. 
 
Materials 
Chitosan (CS) was purchased from Mian Scientific Company, Lahore, Pakistan and further 
purified in our laboratories as previously described32, 33(degree of deacetylation (DD) 84%; 
Mw: 87047.26 g/mol). Poly (vinyl alcohol) (PVA) (Mw: 72,000, degree of hydrolysis 98%), 
hydrochloric acid (HCl) and sulfuric acid (H2SO4) were purchased from Merck (Germany). 
Triethyl orthoformate (98%) was purchased from Alfa Aesar (Germany). Glacial acetic acid 
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(CH3COOH) was purchased from AnalaR BDH Laboratory Supplies (UK). NaOH was 
purchased from Sigma Aldrich. Lysozyme was bought from Carbosynth Limited (UK), 
Toluidine Blue was purchased from Peking Chemical Works (China) and MTT was supplied 
by Sigma-Aldrich.  
Human Breast cancer cell line MDA-MB-231 was employed to study the cytotoxicity of all the 
hydrogels. DMEM medium and fetal bovine serum (FBS) were purchased from GIBCO life 
technologies. 
Preparation of CS/PVA Cross-linked Hydrogels 
The CS (2.5% w/v) was dissolved in acetic acid (1%) aqueous solution and stirred magnetically 
for 12 hours at room temperature (RT). In a separate flask, PVA (10% w/v) was dissolved in 
GLVWLOOHGZDWHUDWÛ&XQGHUPDJQHWLFVWLUULQJ for 2 hours. Then the two solutions were mixed in 
80:20 (v/v) ratios of CS and PVA, and further stirred for 24 hours at RT. The resulting solution 
was then cast into petri dishes and the dishes were frozen at -Û&IRUKRXUV7KHVDPSOHV
were lyophilized for 24 hours in a freeze dryer at -Û& 7KHn lyophilized hydrogels were 
rehydrated and soaked either without (Control) or with 4% or 16% TEOF w/v,-referred to as 
Control, 4 CLH, 16 CLH) in sulfuric acid (17% w/v) for 24 hours. The hydrogels were then 
removed from petri dishes and were neutralized with NaOH (12% w/v) for one hour then washed 
with distilled water three times and then lyophilized again for 24 hours. 
Morphology of hydrogels assessed by Scanning Electron Microscopy 
The morphology of hydrogels (before and after heparin loading) was studiedobserved by SEM. 
The samples were mounted on a stub with conducting copper tape with a Nova NanoSEM-450. 
The SEM was operated at 10kV under low vacuum mode at 50Pa. The pore diameter was 
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calculated using image processing software (Image J). The diameter was of the pores was 
calculated from an average of 30 randomly selected pores. 
 
Analysis of Chemical Structure of hydrogels 
The structural analysis of the hydrogels (before and after heparin loading) was assessed by 
Fourier Transform Infrared Spectroscopy using Thermo Nicolet 6700P, USA. Each spectrum 
was recorded in the range of 4000-400 cm-1 and was an average of 256 scans at 8 cm-1 
resolution. 
Thermal Analysis of stability of hydrogels 
The thermal stability of the samples was analyzed by Thermogravimetric analysis (TGA) and 
Differential Scanning Calorimetry (DSC) using SDT Q 600(USA). Thermograms were obtained 
from 25-600ÛC at a heat ramp of 10 ÛC/min under inert nitrogen environment. 
Swelling Properties 
 The swelling behavior of cross-linked hydrogels was observed by soaking them in phosphate 
buffered saline (PBS). The samples were cut into small pieces of approximately equal weight 
and weighed then submerged in PBS solution at 37 ÛC for 3 hours. The samples were withdrawn 
after the intervals of 15min, 1, 2 and 3 hours and blotted dry and weighed again. The percentage 
degree of swelling was measured by following formula: 
Degree of Swelling (%) = [(Ms-Mi)/Mi] × 100 
where, Ms is the mass of hydrogel after swelling and Mi is the initial mass of the sample taken. 
In vitro degradation  
7 
 
Degradation tests were carried out gravimetrically for each sample composition (n = 3). The 
hydrogels were weighed (W1). Then the samples were kept in phosphate buffered saline (PBS) 
and/or lysozyme solution (1 mg/ml) at 37oC for different time points (day 2 [D2], day 6 [D6], 
and day10 [D10]). The samples were taken out at each time point, dried at 37oC for 24 hours and 
subsequently weighed (W2). The dried weight (without water content) remaining ratios were 
determined as following: 
Dry weight remaining ratio (%) = W2 / W1 × 100 
Heparin Loading 
Heparin was loaded onto the cross-linked hydrogels.  To load heparin, a solution was prepared 
containing WHAT VOLUME OF 10mg/mL (w/v, 10mL) of heparin. Then the cross-linked 
scaffolds (7 × 3 cm) ( WHAT WEIGHT OR SIZE? )were submerged in this solution, overnight 
at RT. The scaffolds absorbed almost all of these solutions. The resulting heparin containing 
scaffolds were frozen at -20 ÛC and finally lyophilized at -40 ÛC for 24 hours. 
Toluidine Blue assay 
Toluidine blue (25mg/100mL) was dissolved in HCl (0.01N) with NaCl (2% w/v). Thin (0.5 
mm) HOW THIN?sections of hydrogel were cut and placed on a glass slide. The toluidine blue 
solution was added drop wise onto the samples and left to stand for 24 hour. After staining, the 
hydrogels were washed for 10min with distilled water to remove unbound toluidine blue. Then 
the samples were air dried and observed under a microscope for the presence and distribution of 
heparin in the hydrogels. 
MTT Assay 
Formatted: Font color: Red
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Cellular toxicity was determined using aby 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrasodium bromide (MTT) assay. Prior to cell culture, all the scaffolds (1 cm2) 
included in this study, a) control hydrogels, b) 4 CLH and c) 16 CHL, were sterilized in 70% 
ethanol for 30 minutes. Immediately before cell seeding the scaffolds were washed 2-3 times 
with PBS and pre-conditioned in DMEM medium for 20 minutes. MDA-MB-231 cells were 
seeded in 24-well cell culture plate with 5×104 cells per well with or without hydrogels in 1 ml 
medium.  Cells seeded in 24-plate wells without hydrogels were used as a positive control. On 
day 5 the medium was discarded and cells were washed with 1 ml PBS. 1 ml (0.5 mg/ml) MTT 
solution was added to each well and the plate was incubated at 37oC for 3 hrs. The MTT solution 
was discarded and the cells/scaffolds were washed once with 1 ml PBS.  To solubilize the 
formazan crystals 0.5 ml dimethyl sulfoxide (DMSO) was added to each well and the plate was 
kept under shaking conditions for 10-20 minutes.  The optical density (OD) of the dissolved 
crystals was measured by using a microplate reader at 590 nm. The assay was set up in triplicates 
for each composition. % Viability is represented as the mean ± SD of 3 independent 
experiments. % Viability was calculated using the following formula: 
% Viability =  ୅ୠୱ୭୰ୠୟ୬ୡୣሺୱୟ୫୮୪ୣሻି୅ୠୱ୭୰ୠୟ୬ୡୣሺ୆୪ୟ୬୩ሻ୅ୠୱ୭୰ୠୟ୬ୡୣሺୡ୭୬୲୰୭୪ሻି୅ୠୱ୭୰ୠୟ୬ୡୣሺ୆୪ୟ୬୩ሻ ൈ  ? ? ? 
Assessment of Angiogenic Properties of Hydrogels using the Chick Chorionic Allantoic 
MembraneCAM ( CAM) Assay 
Fertilized chicken eggs were purchased from Big bird (Lahore, Pakistan) and incubated from day 
2 of fertilization until day 8 at 37°C in a humidified egg incubator (R-COM Suro20). At day 8, a 
square window (1 cm2) was cut into the shell and lifted, and a 1 cm2 hydrogel piece was placed 
onto the chorionic allantoic membraneCAM. The hydrogel pieces implanted were squares of 1-2 
Formatted: Font: Bold
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x1 cm .or circular in which case 1cm diameter?) Each egg was implanted with one piece of 
hydrogel only. The shell window was replaced with parafilm (Bemis Flexible Packaging, USA) 
and sealed with adhesive tape. After implantation, eggs were placed again at 37°C in a 45% 
humidified incubator until day 14. At day 14, the eggs were sacrificed. Angiogenesis was 
quantified by taking light microscope pictures of the material on the CAM and then hydrogels 
were removed for further analysis. Figure 1 shows a protocol of this CAM assay.  
Each group contained material added to 10 fertilised eggs. Only results from surviving 
developing chicks were used. On average chick survival was 80%. 
 
 
 
[Insert Figure 1] 
Figure 1: Schematic diagram of CAM Assay 
 
Results and discussion 
Chemistry 
This study is an extension of our previous published work, in which we introduced triethyl 
orthoformate as a new cross-linking agent34. In this study we compared two different 
concentrations of cross-linker (4% and 16%) to check its effect on the morphology, thermal 
stability, biodegradation and biocompatibility of prepared cross-linked hydrogels. The scaffolds 
were then loaded with heparin to check their angiogenic behavior. 
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The cross-linked hydrogels were prepared by mixing the CS and PVA solutions in an 80:20 ratio 
and then lyophilizing at -40°C. The samples were then rehydrated and cross-linked using 
different concentrations of TEOF (4% and 16%) in sulfuric acid. Controls were devoid of any 
cross-linker. Then NaOH solution was used to neutralize the cross-linked hydrogels. The 
samples were again lyophilized at -40°C to gel porous hydrogels, which was confirmed by SEM 
images of these scaffolds. The chemical nature of cross-linking was revealed by FTIR analysis 
and thermal stability was investigated by TGA and DSC.  
 
Figure 2 shows the protocol for the preparation of porous heparin-loaded hydrogels and 
photographs of the appearance of these.  
 
[Insert Fig 2] 
Figure 2: Schematic diagram for the preparation of control (not cross-linked), 4CLH and 16 
CLH. 
 
Scanning Electron Microscopy of hydrogels  
The surface morphology of freeze-dried cross-linked hydrogels revealed a highly porous nature. 
It is known that the microstructure of hydrogels can influence cell infiltration, proliferation and 
function in tissue engineering 35, 36. The morphologies of the cross-linked CS/PVA scaffolds 
before and after heparin loading are shown in Figure 3. The interconnected porous structure of 
the scaffolds was retained after heparin loading; however, some other significant changes 
occurred with respect to pore size and morphology. The hydrogels without TEOF were taken as 
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the reference control. The mean pore sizes, before drug loading, were 4.85 µm±2.26 µm for the 
control, 4.73 µm±1.92 µm for 4 CHL and 3.35 µm±2.05 µm for 16 CLH. After heparin loading 
and freeze drying again, the pore sizes were increased, a little, to 5.37 µm±2.50 µm, 5.22 
µm±2.08 µm, 4.58 µm±1.59 µm for control, 4 CLH and 16 CLH, respectively. There was a 
reduction in the fibrous extensions in between pores and more sheet-like structures appeareding 
post heparin loading. The scaffolds were freeze dried again after heparin loading.  
It was observed that the pore size decreased slightly, in both the unloaded and heparin-loaded 
scaffolds, as the amount of cross-linker was increased in the samples. The pore sizes decreased 
as follows: Control > 4 CLH >16 CLH 
 
 
[Insert Fig 3] 
Figure 3: Scanning Electron Microscope micrographs of cross-linked CS/PVA hydrogels, before and after heparin 
loading and control (without TEOF) (MAll images magnifications bars are given with each images). Unpaired t-test 
was performed to check whether the difference between pre-size values was significant or not. It was found that the 
pore-size differences between control and 4 CLH wereas not significant (p=0.7699), again between 4 CLH and 16 
CLH the differences wereas not significant (p=0.0741) b. But the difference between the pore-size of the control and 
16 CLH was significant (p=0.0018). 
 
 
 
 
Chemical Structure Analysis by FTIR 
The FTIR spectra of all PVA and CS samples are shown in Figure 4 (a-f). FTIR spectra of all 
the samples confirmed their chemical structure.  For CS and PVA, a broad peak from 3500-3200 
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cm-1 is assigned to O-H and N-H stretching vibrations.37, 38 The sharp peaks around 2900 cm-1 in 
spectra are assigned to C-H stretching vibrations.39 A peak observed at 1530 cm-1 in PVA 
spectrum (Fig. 3f) was assigned to O-H bending vibrations.40 The bands at 1113 cm-1 and 1047 
cm-1 are assigned to C-O and C-O-C stretching vibrations respectively.41 
The FTIR spectra of all cross-linked composites of PVA and CS with different ratios of TEOF 
(Figure 4, b-e) were found to possess all the major spectral peaks of CS and PVA. All the 
samples showed a broad peak from 3500-3200 cm-1 for O-H and N-H stretching vibrations. 
The peaks near 2900 cm-1 were assigned to C-H stretching vibrations. The bands appeared 
near 1400 cm-1 was due to C-H bending vibrations. The peaks at 1099 cm-1 are due to C-O-C 
stretching vibrations.  
In the cross-linked hydrogel spectra (Figure 4, b-d), a broad peak for O-H and N-H stretch  
also appeared at 3400-3200 cm-1, but the intensity of this peak was decreased significantly 
due to a decrease in number of -NH2 groups on the CS skeleton. This can be further explained 
on the basis of chemical crosslinking of the CS. This was due to a reaction between -NH2 
groups of CS and TEOF resulting in a Schiff base, which was verified by the presence of a 
new band at 1630 cm-1, associated with the ±C=N imine group in cross-linked hydrogels.42, 43 
[Insert Figure 4] 
Figure 4: FTIR results of PVA, chitosan and cross-linked hydrogels. FTIR spectra in the spectral region (4000-600 
cm-1) for (a) Chitosan (b) Control (c) 4 CLH (d) 16 CLH (e) PVA 
Thermal Analysis of hydrogels 
It is known that PVA is a semi-crystalline polymer in which high physical interactions between 
the polymers chains, due to hydrogen bonding between the hydroxyl groups exist. Similar 
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bonding is also present in chitosan polymer chains. The introduction of a crosslinking agent 
affects both, crystallinity and physical network, originating variations in the Tg values of the 
system. It can be seen from Figure 5 (B), Tg value of control shifted from 58 to 63 °C in case of 
cross-linked hydrogels. An endothermic peak at 190°C, in the control hydrogel thermogram, that 
represented the melting point (Tm) of PVA, was also shifted to higher temperature in the case of 
cross-linked hydrogels. Similarly, the thermal degradation of chitosan was at 270°C, while in 
cross-linked hydrogels it shifted to 300 °C. The endothermic peak after 450 °C represented the 
thermal degradation of all polymeric content. The shifting of peaks of cross-linked hydrogels 
toward higher temperatures indicated that the cross-linked hydrogels are thermally more stable 
than the control one. 
The thermal stability of cross-linked hydrogels was also confirmed by thermogravimetric 
analysis. The first degradation step, at 60±85 °C, could be ascribed to the removal of traces of 
water or solvent vapor which showed a 10% weight loss in control but only a 2-5% loss in the 
cross-linked hydrogels. The second degradation step was between 190-300 °C in the case of 
control and 200-350 °C in cross-linked hydrogels. This resulted in the highest residual weight 
loss and this was due to the decomposition and volatilization of organic components of polymer. 
In this step, control showed 50% weight loss but cross-linked hydrogels showed only a 30-40% 
weight loss. The thermal decomposition temperature (Td) range of cross-linked hydrogels shifted 
significantly towards temperature ranges higher than those of control. The third decomposition 
step was after approximately 450 °C. This was mainly the organic residues that were completely 
volatilized. In this step too, the control showed more weight loss than the cross-linked hydrogels. 
It was interesting to see that as the percentage of cross-linker is increased in the hydrogels, the 
weight loss decreased. This indicated that the hydrogels are becoming thermally more stable as 
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the amount of cross-linker was increased in the samples. In TG thermograms, controls showed a 
total weight loss of around 85% while hydrogels with 16% cross-linker showed less than 60% 
total weight loss. 
The overall order of thermal stability of hydrogels was: 
 
[Insert Figure 5] 
Figure 5: (A) Thermogravimetric and (B) Differential Scanning Calorimetry thermograms of hydrogels (control and 
cross-linked) in the temperature range of 0-600°C. 
 
Swelling Properties of hydrogels 
The ability of a scaffold to attract water is an important property for tissue engineering 
particularly skin tissue engineering. The prepared hydrogels were soaked, in triplicates, in 
phosphate buffer saline (PBS) solution for one hour to 24 hours,  to check their swelling 
behavior. The swelling ratios of the scaffolds are shown in Figure 6. The swelling of the control 
(without cross-linker) scaffold was clearly more thanalmost double that of the TEOF treated 
scaffolds. There was no significant difference in swelling between those with 4 or 16 % 
crosslinker.  
The water-binding ability of the chitosan/PVA scaffold could be attributed to both their 
hydrophilicity and the maintenance of their three-dimensional structure. TIn general, the ability 
of the hydrogels to swell ing ratio decreased dramatically when hydrogels wereas the cross-
linked. degree increased because of the decrease of the hydrophilic groups. The results in Figure 
4 suggest that the primary factor affecting the swelling property is the degree of cross-linking. 
The swelling studies were well-supported by SEM results which showedtated that as the degree 
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of crosslinking was increased the average pore-size was decreased slightly .which in result 
affected the swelling (solution absorption) of hydrogels.  
Thus the cross-linker has affected the pore size (Figure 3) and hydrogel swelling. It is well-
known that cross-linkers improve the mechanical strength of hydrogels 44-48 and help maintain 
their physical structure in media. As expected therefore in this case the hydrogel with 16% 
crosslinker showed slightly less swelling compared to the one with only 4% 
crosslinker.CANNOT BE SIGNIFICANT AND MISLEADING TO SUGGEST IT IS>>> 
 
[Insert Figure 6] 
Figure 6: Solution absorption (%) of control and cross-linked CS/PVA hydrogels.  Values shown are means with  
1 standard deviation either side of n=3??? rReplicates. 
 
Degradation Studies 
Lysozyme is an enzyme which is known for its degradation of natural polymers (chitosan, chitin 
and collagen etc.) which contain a 1,4-ȕ-linkage. Our in vitro degradation results are 
demonstrated in Figure 7. To mimic the in vivo degradation process, lysozyme (1 mg/ml) was 
added to PBS. However, our data indicated that hydrogels showed comparable degradation rates 
irrespective of the presence or absence of lysozyme. In control samples (Figure 7A), the dry 
weight ratio was decreased progressively from 100 % to 72 % (± 4 %) in PBS and to 71 % (± 3 
%) in PBS / lysozyme solution during the 10 days of degradation. The 4 CLH showed a decrease 
from 100 % to 56 % (± 21 %) and 49 % (± 12 %) in PBS and PBS / lysozyme solution 
respectively during 10 days of degradation (Figure 7B). HSimilarly hydrogels with an increased 
cross-linker concentration of 16 % showed a decrease in dry weight ratio from 100 % to 56 % (± 
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12 %) in PBS to 63 % (± 6 %) in PBS / lysozyme solution during 10 days of degradation 
(Figure 7C). Overall, the decrease in degradation was slightly  not-significantly ) greater for the 
cross-linked hydrogels than for the non-cross linked hydrogels by 10 days .which confirms that 
cross-linking is affecting the rate of degradation of these materials but Tthis breakdown of 
hydrogels was not accelerated by the addition of lysozyme. 
[Insert Figure 7] 
Figure 7: Measurement of rate of breakdown of hydrogels in PBS and lysozyme. Dry weight remaining ratio (%) 
chitosan/PVA hydrogels in PBS and 1mg / ml lysozyme / PBS at 37°C at different time points: A) Chitosan/PVA 
(control), B) 4 CLH, C) 16 CLH. Graphical data is presented as mean (n=3)?  ± strandard deviation of three 
independent experiments. 
Toluidine Blue assay 
A toluidine blue assay was performed to confirm the presence of heparin in the samples (Figure 
8). For this purpose, very thin (0.5 mm) HOW THIN???sections of hydrogels (control, 4 CLH 
and 16 CLH) were cut and stained with toluidine blue for 24 hours. Then the samples were 
washed with distilled water for 10min to get rid of excessive toluidine blueheparin. Then the 
images were captured using an inverted microscope (Euronext, IN-2053). Heparin forms a purple 
complex with toluidine blue while toluidine itself is blue. ThusSo the formation of a purple 
complex confirms the presence of heparin. From the images it can be seen that heparin was 
uniformly distributed in the samples. The control samples were blue in color while the heparin-
loaded scaffolds changed towards shades of purple (4CLH and 16 CLH). From Figure 8 it can 
be seen that 16 CLH had a darker shade of purple indicative of retaining more heparin than 4 
CLH.  
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These results were supported by the effects of the hydrogels in the CAM assay (Figure 10, 11) 
where 16 CLH was seen to be showed more angiogenic activity than 4 CLH.  
[Insert Figure 8] 
Figure 8: Inverted mMicroscope images of control (without heparin), 4 CLH and 16 CLH. 
Use of MTT Assay to demonstrate cell compatibility of hydrogels 
The MTT assay was used to examine the viability and growth of the breast cancer cell line 
MDA-MB-231 grown for 5 days with control (hydrogel without cross-linker, TEOF) 4 CLH and 
16 CLH. Results demonstrate no significant difference in % viability of cells grown with the 
different hydrogels compared with control (tissue culture plate-TCP) (Figure 9) showing that 
none of these hydrogels alter the proliferation capacity and viability of the MDA-MB-231 cell 
line.  
[Insert Figure 9] 
Figure 9: Effect of hydrogels on cell viability.   Viability of breast cancer cell line (MDA-MB-231) seeded in 
tissue culture plate controls (TCP) (no hydrogel), with control hydrogel (no cross-linker), and with 4 CLH & 16 
CLH for 5 days as determined by MTT assay. Bars represent mean cell viability normalized to control cells and 
error bars depict the standard deviation of duplicate experiments (n = 2). Statistical analysis (one-way ANOVA, 
6LGDN¶V PXOWLSOH FRPSDULVRQV WHVW VKRZHG QR-significant difference (p= 0.0901) between the TCP and tested 
materials (control, 4 CLH and 16 CLH). 
Assessment of Angiogenic Properties of Hydrogels using CAM Assay 
 The chick chorionic allantoic membrane (CAM) was performed to explore the angiogenic 
response to the hydrogels. A small window was made in the shell on day 7 of chick embryos and 
a 1 cm2 hydrogel piece was placed onto the CAM. Each egg was implanted with one piece of 
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hydrogel only (n=5or 10 ??). The chick embryos were incubated with the hydrogels grafts until 
day 14 of development.  
The samples retrieved from the CAM assay, after sacrificing the eggs, were then fixed with 
paraformaldehyde and then dehydrated using gradient solutions of ethanol (50-100%). A small 
portion of the hydrogels was cut to see the cross sectional area of the scaffold and to see the 
blood vessel ingrowth. The results are shown in Figure 10. 
 
[Insert figure 10] 
Figure 10: Colorimeatric quantification of blood vessels from images of scaffolds retrieved from CAM assay. The 
upper images show light microscopic images of control (without heparin) and heparin-loaded hydrogels CLH 4 and 
CLH 16. These were than photographed and the histograms show the amounts of red and blue color in these samples 
where the red color intensity representings the number of blood vessels.  ZD\ $129$ 'XQQHWW¶V 0XOWLSOH
comparison test (**** p< 0.0001).  Statistical analysis (ZD\$129$'XQQHWW¶V0XOWLSOHFRPSDULVRQWHVW) showed 
significant difference (**** p< 0.0001) between the tested materials (control, 4 CLH and 16 CLH).  
 
 
NEED MORE EXPLANATIONStatistical analysis T Results Graphical results are presented as means ±1 standard 
deviation of n=8-??? rReplicates (10 fertilized eggs were used per sample and on average 8 were survived per 
batch).. 
 
The ability of heparin to support blood vessel growth was also evaluated by SEM. The samples 
were retrieved at day 14 and assessed for vessel ingrowth. Cross sections of hydrogels 
showedverified the ingrowth of blood vessels and the heparin-loaded cross-linked hydrogels 
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displayed greater angiogenic activity than the control hydrogels. The blood vessels penetrating 
the scaffolds appeared to be round as shown in Figure 11. 
It was also observed from SEM images that erythrocytes adhered to the hydrogel surface of both 
control and heparin-loaded hydrogels-this also confirmed the non-toxic behavior of these 
biomaterials. 
 
[Insert Figure 11] 
Figure 11: SEM images of paraformaldehyde fixed explanted scaffolds from CAM at day 14. Yellow arrows are 
indicate the pointing blood vessels. 
 
Conclusions 
The hydrophilic nature of chitosan and PVA was used to develop cross-linked hydrogels using 
twovariable concentrations of triethyl orthoformate (TEOF) as a cross-linker -4 and 16%(4 
CLH and 16 CLH.). The resulting cross-linked hydrogels were then loaded with heparin, by 
physical adsorption, to evaluate their pro-angiogenic behavior. The hydrogels were characterized 
by SEM, FTIR and DSC/TGA to assess the effect of cross-linker on the morphology, porous and 
chemical structure and thermal stability of the cross-linked hydrogels. The hydrogels showed 
swelling properties and bio-compatibility. Degradation studies were also performed in PBS and 
using lysozyme which showed that the cross-linking somehow facilitated the degradation of 
these hydrogels.Increasing the concentration of cross-linker reduced the extent of swelling of the 
hydrogels, had a very small effect on pore size (reducing these slightly at 16%) but had no 
appreciable effect on the rate of breakdown of the hydrogels which lost approximately 37%  in 
weight by 10 days in PBS and this was not affected much by the addition of lysozyme where 
there was a 44 % loss in weight over 10 days.  NOT REALLY The presence and uniform 
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distribution of heparin in hydrogels was confirmed by the toluidine blue assay. The CAM assay 
showed the pro-angiogenic behavior of these cross-linked hydrogels andwhere SEM of CAM 
retrieved hydrogels showed clear growth of blood vessels into 4 CLH and 16 CLH scaffolds. 
Although crosslinker did not affect much the physio-chemical properties however the The 
greatest effect of the crosslinking was seen in the ability of the cross-linked hydrogels to bind 
heparin and induce angiogenesis compared to the non-crosslinked materials. Here there was a 
significant effect of using 16% rather than 4% cross-linker. In conclusion, we have prepared new 
cross-linked, biodegradable and non-toxic hydrogels which bind heparin, and which without the 
need to add any further costly growth factors, show pro-angiogenic activity.  We suggest these  
highly cross-linked hydrogels will be of value for skin tissue engineering applications as they 
will allow tissue ingrowth to form a neo-dermis while promoting new blood vessel formation.  
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